I am a clinician scientist trained in General Pediatrics, Pediatric Gastroenterology and Clinical Nutrition and with a clinical and research interest in inflammatory bowel diseases (IBD). The focus of my research is to discover underlying mechanisms and better therapeutic approaches in the broad area of chronic inflammation and mucosal healing as it relates to adult and pediatric patients with IBD. A particular emphasis currently is to define novel ways in which the course of Crohn’s disease can be altered by specific modulation of the monocyte compartment and the innate immune response. My second focus area is determining the molecular basis for the role of myeloid-derived regulatory cells in mouse genetic and experimental models of colitis. My clinical research endeavours involve patient-based approaches to develop new prognostic biomarkers in IBD. I am also actively involved in ongoing multi-centre investigator-initiated and industry-supported clinical trials of new therapeutics and quality improvement efforts.